| Literature DB >> 32715634 |
Wannapha Nobnop1,2, Panchalee Phakoetsuk3, Imjai Chitapanarux1,2,4, Damrongsak Tippanya1, Darat Khamchompoo3.
Abstract
PURPOSE: To compare dose to the targets and organs at risk (OARs) in different situations for postmastectomy patients who require radiation to the chest wall with or without regional nodal irradiation when using three treatment techniques. METHODS AND MATERIALS: Thirty postmastectomy radiotherapy (PMRT) patients previously treated by helical tomotherapy (HT) at our institution were identified for the study. The treatment targets were classified in three situations which consisted of, the chest wall (CW) only, the chest wall plus supraclavicular lymph nodes (CW + SPC), and the chest wall plus supraclavicular and whole axillary lymph nodes irradiation (CW + SPC+AXLN). The volumetric modulated arc therapy (VMAT) plans and Tomodirect (TD) plans were created for each patient and compared with HT treatment plans which had been treated. The target coverage, dose homogeneity index (HI), conformity index (CI), and dose to OARs were analyzed. The quality scores were used to evaluate the appropriate technique for each situation from multiparameter results.Entities:
Keywords: IMRT; TomoDirect; VMAT; helical tomotherapy; postmastectomy
Mesh:
Year: 2020 PMID: 32715634 PMCID: PMC7497934 DOI: 10.1002/acm2.12989
Source DB: PubMed Journal: J Appl Clin Med Phys ISSN: 1526-9914 Impact factor: 2.102
Fig. 1The coronal view of the computed tomography (CT) images and structure for the patients (a) the first situation (chest wall only), (b) the second situation (chest wall included supraclavicular lymph nodes), and (c) the third situation (chest wall included supraclavicular and axillary lymph nodes irradiation).
The dose constraints for postmastectomy radiotherapy (PMRT) patients with irradiated planning target volume (PTV) chest wall (CW) and chest wall plus regional nodes (CW + RN).
| Structure | Chest wall only irradiation | Chest wall + regional nodes irradiation | ||
|---|---|---|---|---|
| Dose (Gy) | Volume (%) | Dose (Gy) | Volume (%) | |
| PTV (CW, CW + RN) | <53.5 | 2 | <53.5 | 2 |
| 50 | 50 | 50 | 50 | |
| >47.5 | 95 | >47.5 | 95 | |
| Ipsilateral lung | 20 | 20 | 20 | 30 |
| 30 | 20 | |||
| Contralateral lung | 5 | 10 | 5 | 20 |
| Contralateral breast | 5 | 10 | 5 | 10 |
| 8 | 2 | 8 | 2 | |
| Heart | 20 | 15 | 20 | 15 |
| 10 | 20 | 10 | 20 | |
| Heart (mean dose) | 8 | 8 | ||
| Spinal cord | 20 | 2 | 20 | 2 |
| Left anterior descending artery (LAD) | 50 | 2 | 50 | 2 |
| Esophagus | 52.5 | 2 | 52.5 | 2 |
Fig. 2The dose distribution of coronal plane by TomoDirect (TD), Helical tomotherapy (HT) and Volumetric modulated arc therapy (VMAT) plans for three situations of patient (a) chest wall only; CW, (b) chest wall + supraclavicular lymph nodes; CW + SPC and (c) chest wall + supraclavicular nodes + axillary nodes; CW + SPC + AXLN irradiation.
Mean and standard deviations of dose parameters in three treatment techniques.
| Variables |
TD Mean (SD) |
HT Mean (SD) |
VMAT Mean (SD) |
|
|---|---|---|---|---|
| CW only | ||||
| ‐PTV CW | ||||
| V95% | 95.3 (0.7) | 98.8 (0.6) | 95.5 (1.6) | <0.01 |
| HI | 0.153 (0.015) | 0.089 (0.009) | 0.142 (0.012) | <0.01 |
| CI | 0.709 (0.122) | 0.808 (0.079) | 0.768 (0.119) | <0.01 |
| CW + SPC | ||||
| ‐PTV CW | ||||
| V95% | 95.7 (0.8) | 97.4 (0.8) | 95.6 (0.7) | <0.01 |
| HI | 0.149 (0.012) | 0.101 (0.020) | 0.174 (0.024) | <0.01 |
| CI | 0.657 (0.130) | 0.816 (0.089) | 0.788 (0.112) | <0.01 |
| ‐PTV RNI | ||||
| V95% | 98.8 (0.7) | 99.8 (0.2) | 98.6 (1.4) | <0.01 |
| HI | 0.085 (0.021) | 0.071 (0.011) | 0.152 (0.065) | <0.01 |
| CW + SPC + AXLN | ||||
| ‐PTV CW | ||||
| V95% | 95.7 (0.4) | 97.1 (0.9) | 95.3 (0.5) | <0.01 |
| HI | 0.144 (0.014) | 0.112 (0.012) | 0.176 (0.023) | <0.01 |
| CI | 0.683 (0.189) | 0.790 (0.101) | 0.761 (0.106) | <0.01 |
| ‐PTV RNI | ||||
| V95% | 98.9 | 99.7 | 98.1 | <0.01 |
| HI | 0.088 (0.019) | 0.063 (0.011) | 0.112 (0.027) | <0.01 |
Abbreviations: AXLN, axillary nodes; CI, conformity index; CW, chest wall; HI, homogeneity index; HT, TomoHelical; PTV, planning target volume; RNI, regional nodes; SPC, supraclavicular lymph nodes; TD, TomoDirect; VMAT, volumetric modulated arc therapy.
Mean and standard deviation of dose parameters for the organs at risk.
| Structure | Metric |
TD Mean (SD) |
HT Mean (SD) |
VMAT Mean (SD) |
|
|---|---|---|---|---|---|
| CW only | |||||
| Ipsilateral lung | V20Gy | 27.0 (6.3) | 20.2 (1.2) | 19.4 (1.4) | 0.04 |
| Contralateral lung | V5Gy | 8.6 (3.6) | 8.0 (1.8) | 8.0 (3.3) | 0.01 |
| Contralateral breast | V5Gy | 2.4 (1.5) | 8.8 (1.8) | 8.5 (2.6) | <0.01 |
| D2% | 6.9 (3.6) | 7.1 (0.5) | 7.8 (1.5) | 0.27 | |
| Heart | V20Gy | 19.8 (8.7) | 14.0 (2.3) | 12.9 (1.5) | 0.06 |
| V10Gy | 41.5 (7.0) | 70.9 (6.0) | 39.8 (8.4) | <0.01 | |
| Dmean | 12.7 (2.8) | 14.2 (0.7) | 11.2 (0.9) | <0.01 | |
| LAD | Dmax | 44.6 (3.4) | 43.3 (4.5) | 44.5 (3.2) | 0.51 |
| Spinal cord | Dmax | 6.0 (4.0) | 13.0 (1.4) | 8.9 (2.9) | <0.01 |
| Esophagus | Dmax | 15.0 (20.1) | 18.8 (3.1) | 15.2 (2.4) | <0.01 |
| CW + SPC | |||||
| Ipsilateral lung | V20Gy | 37.0 (5.7) | 26.9 (1.9) | 36.7 (4.0) | <0.01 |
| V30Gy | 26.9 (5.1) | 18.3 (1.4) | 20.0 (1.6) | <0.01 | |
| Contralateral lung | V5Gy | 8.9 (3.3) | 14.8 (3.0) | 17.4 (2.3) | <0.01 |
| Contralateral breast | V5Gy | 5.9 (4.0) | 11.6 (2.5) | 8.8 (1.0) | <0.01 |
| D2% | 11.0 (8.2) | 7.4 (0.6) | 6.1 (0.2) | 0.02 | |
| Heart | V20Gy | 25.5 (8.8) | 20.5 (9.8) | 15.2 (3.6) | <0.01 |
| V10Gy | 45.7 (12.4) | 71.5 (10.8) | 60.1 (6.9) | <0.01 | |
| Dmean | 15.1 (2.0) | 15.8 (1.1) | 13.5 (1.1) | <0.01 | |
| LAD | Dmax | 45.4 (12.3) | 49.5 (1.6) | 47.0 (1.2) | <0.01 |
| Spinal cord | Dmax | 11.2 (2.1) | 25.1 (4.7) | 16.6 (0.8) | <0.01 |
| Esophagus | Dmax | 50.9 (1.4) | 50.7 (0.6) | 49.1 (0.9) | 0.02 |
| CW + SPC + AXLN | |||||
| Ipsilateral lung | V20Gy | 38.3 (4.7) | 28.1 (1.7) | 37.3 (3.5) | <0.01 |
| V30Gy | 27.8 (2.7) | 19.3 (1.0) | 20.2 (1.6) | <0.01 | |
| Contralateral lung | V5Gy | 14.9 (5.4) | 15.9 (1.6) | 15.6 (5.1) | 0.74 |
| Contralateral breast | V5Gy | 8.8 (6.4) | 12.3 (1.7) | 10.8 (5.0) | <0.01 |
| D2% | 11.3 (7.6) | 7.5 (0.6) | 6.2 (0.6) | <0.01 | |
| Heart | V20Gy | 25.7 (9.7) | 16.8 (2.7) | 15.2 (2.2) | 0.01 |
| V10Gy | 54.9 (7.0) | 75.5 (5.4) | 62.6 (5.8) | <0.01 | |
| Dmean | 15.3 (2.3) | 16.0 (0.7) | 13.6 (1.0) | <0.01 | |
| LAD | Dmax | 47.9 (2.9) | 50.1(1.5) | 45.1 (4.6) | <0.01 |
| Spinal cord | Dmax | 9.8 (2.3) | 21.7 (2.8) | 15.7 (1.0) | <0.01 |
| Esophagus | Dmax | 49.3 (2.7) | 50.0 (1.3) | 47.4 (3.3) | <0.01 |
Abbreviations: AXLN, axillary nodes; CI, conformity index; CW, chest wall; HI, homogeneity index; HT, TomoHelical; LAD, left anterior descending artery; SPC, supraclavicular lymph nodes; TD, TomoDirect; VMAT, volumetric modulated arc therapy.
Planned score table of the three treatment techniques for three situations.
| Structure | Metric |
TD Mean (SD) |
HT Mean (SD) |
VMAT Mean (SD) |
|---|---|---|---|---|
| CW only | ||||
| PTV CW | V95% | 0 | 1 | 0 |
| HI | 0 | 1 | 0 | |
| CI | 0 | 1 | 0 | |
| Ipsilateral lung | V20Gy | 0 | 1 | 1 |
| Contralateral lung | V5Gy | 0 | 0 | 0 |
| Contralateral breast | V5Gy | 1 | 0 | 0 |
| D2% | 0 | 0 | 0 | |
| Heart | V20Gy | 0 | 0 | 0 |
| V10Gy | 1 | 0 | 1 | |
| Dmean | 1 | 0 | 1 | |
| LAD | Dmax | 0 | 0 | 0 |
| Spinal cord | Dmax | 1 | 0 | 1 |
| Esophagus | Dmax | 1 | 0 | 0 |
| Total score | 5 | 4 | 4 | |
| CW + SPC | ||||
| PTV CW | V95% | 0 | 1 | 0 |
| HI | 0 | 1 | 0 | |
| CI | 0 | 1 | 0 | |
| PTV RNI | V95% | 0 | 1 | 0 |
| HI | 0 | 1 | 0 | |
| Ipsilateral lung | V20Gy | 0 | 1 | 0 |
| V30Gy | 0 | 1 | 1 | |
| Contralateral lung | V5Gy | 1 | 0 | 0 |
| Contralateral breast | V5Gy | 1 | 0 | 1 |
| D2% | 0 | 0 | 1 | |
| Heart | V20Gy | 0 | 1 | 1 |
| V10Gy | 1 | 0 | 0 | |
| Dmean | 0 | 0 | 1 | |
| LAD | Dmax | 1 | 0 | 1 |
| Spinal cord | Dmax | 1 | 0 | 0 |
| Esophagus | Dmax | 0 | 0 | 1 |
| Total score | 5 | 8 | 7 | |
| CW + SPC + AXLN | ||||
| PTV CW | V95% | 0 | 1 | 0 |
| HI | 0 | 1 | 0 | |
| CI | 0 | 1 | 0 | |
| PTV RNI | V95% | 0 | 1 | 0 |
| HI | 0 | 1 | 0 | |
| Ipsilateral lung | V20Gy | 0 | 1 | 0 |
| V30Gy | 0 | 1 | 1 | |
| Contralateral lung | V5Gy | 0 | 0 | 0 |
| Contralateral breast | V5Gy | 1 | 0 | 1 |
| D2% | 0 | 0 | 1 | |
| Heart | V20Gy | 0 | 1 | 1 |
| V10Gy | 1 | 0 | 1 | |
| Dmean | 0 | 0 | 1 | |
| LAD | Dmax | 1 | 0 | 1 |
| Spinal cord | Dmax | 1 | 0 | 1 |
| Esophagus | Dmax | 0 | 0 | 1 |
| Total score | 4 | 8 | 9 | |
Abbreviations: AXLN, axillary nodes; CI, conformity index; CW, chest wall; HI, homogeneity index; HT, TomoHelical; LAD, left anterior descending artery; PTV, planning target volume; RNI, regional nodes; SPC, supraclavicular lymph nodes; TD, TomoDirect; VMAT, volumetric modulated arc therapy.
Fig. 3The transverse view of the computed tomography images of planning target volume chest wall structure (blue color) for one patient for each situation (a) the first situation (chest wall only), (b) the second situation (chest wall included supraclavicular lymph nodes), and (c) the third situation (chest wall included supraclavicular and axillary lymph nodes irradiation).